Capecitabine and Huaier granule intensive therapy:clinical effectiveness and prognosis in patients with triple-negative breast cancer receiving conventional treatmentOA
Capecitabine and Huaier granule intensive therapy:clinical effectiveness and prognosis in patients with triple-negative breast cancer receiving conventional treatment
Zhen-Zhen Bu;De-Hong Yu;Zhuang Zhu;Wen-Han Zhang;Dong-Shen Ma;Ruo-Fei Wang;Xiao-Xiao Liu;Long-Zhen Zhang
Department of Radiation Oncology,Cancer Center,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China||Graduate School,Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Radiation Oncology,Affiliated Pizhou Hospital of Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Radiation Oncology,Cancer Center,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China||Graduate School,Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Radiation Oncology,Cancer Center,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China||Graduate School,Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Pathology,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Information,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Radiation Oncology,Cancer Center,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China||Graduate School,Xuzhou Medical University,Xuzhou 221000,ChinaDepartment of Radiation Oncology,Cancer Center,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China||Graduate School,Xuzhou Medical University,Xuzhou 221000,China
triple-negative breast cancerHuaier granulecapecitabineintensive treatmentprogression-free survivaloverall survivaladverse events
triple-negative breast cancerHuaier granulecapecitabineintensive treatmentprogression-free survivaloverall survivaladverse events
《传统医学研究（英文版）》 2026 (10)
47-58,12
We thank Professor Longzhen Zhang for her contribution to the guidance of this study.Thanks to all the researchers involved in this study:Longzhen Zhang,Xiaoxiao Liu,Zhenzhen Bu,Dehong Yu,Zhuang Zhu,Wenhan Zhang,Dongshen Ma,Ruofei Wang.Funding:Young Talent Program of The Affiliated Hospital of Xuzhou Medical University.Advanced Program of The Affiliated Hospital of Xuzhou Medical University(PYJH2024210).Medical Research Project of Jiangsu Provincial Health Commission(H2023050).National Natural Science Foundation of China(No.32301278).
评论